ARS Pharmaceuticals Financials

$5.62

$-0.05 (-0.88%)

As on 04-Sep-2026 16:10EDT

Market cap

$559 Mln

Revenue (TTM)

$117 Mln

P/E Ratio

--

P/B Ratio

45.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	116.93	84.28	89.15	0.03	1.32	5.51
Cost of Revenue	30.53	20.42	20.56	0.07	17.12	0.21
Gross Profit	86.40	63.86	68.59	0.03	-15.80	5.29
Operating Expenses	302.67	243.30	71.68	67.55	19.71	24.75
Operating Profit (EBIT)	-216.27	-179.45	-3.08	-67.52	-35.52	-19.45
Other Income	--	--	--	--	0.83	--
Profit before Tax	-215.51	-171.38	8.29	-54.37	-34.68	-20.24
Provision for Tax	-0.08	-0.08	0.29	-0.09	-0.69	-0.23
Profit after Tax (Net Income)	-215.43	-171.30	8.00	-54.37	-34.68	-20.24
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-34.68	-20.24

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	12.51	114.26	256.80	230.76	272.89	-31.27
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	176.12	174.25	70.92	0.04	3.11	84.53
Current Liabilities	60.86	39.15	23.44	2.39	5.44	8.19
Total Liabilities	310.36	327.65	351.15	233.19	281.44	61.45

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	37.99	42.76	16.86	1.63	3.74	0.72
Current Assets	211.51	284.90	334.30	231.56	277.70	60.73
Total Assets	310.36	327.65	351.15	233.19	281.44	61.45
Total Debt*	171.60	96.37	0.04	0.27	0.48	9.03
Net Current Assets	150.65	245.75	310.86	229.34	272.26	52.54

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-170.87	13.55	-59.27	-40.08	-17.56
Cash Flow from Investing Activities	--	56.77	-106.10	-87.18	-0.20	-0.06
Cash from Financing Activities	--	104.60	72.40	6.90	190.73	53.16
Net Cash Inflow / Outflow	--	--	--	--	150.46	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.18	-2.18	-1.74	0.08	-0.57	-0.37
Cash EPS ($)	-2.18	-2.18	-1.78	0.01	-0.56	-0.37
Adjusted Book Value ($)	0.13	0.13	1.16	2.62	2.40	2.90
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	-1.73	0.14	-0.62	-0.43
Free Cash Flow per Share ($)	--	--	-1.74	0.13	-0.62	-0.43

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	--	-73.29	3.28	-21.56	-27.62
ROE (%)	-339.88	-339.88	-92.33	3.28	-21.59	-28.71
ROA (%)	-64.36	-64.36	-50.47	2.74	-21.13	-20.23
EBIT Margin (%)	-180.11	-180.11	-200.26	9.29	-181,216.67	-2,635.41
Net Margin (%)	-184.24	-184.24	-203.25	8.97	-181,216.67	-1,613.12
Cash Profit Margin (%)	0.00	0.00	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	4.08	4.08	-0.05	2,970.63	-0.98	-0.76
EBIT Growth (%)	-341.22	-341.22	-2,136.92	115.24	-56.75	-72.23
Net Profit Growth (%)	-7.94	-348.66	-2,241.76	114.71	-56.75	-71.33
EPS Growth (%)	-344.10	-344.10	-22.28	1.14	-0.53	0.36
Book Value Growth (%)	-93.56	-93.56	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	--	-6.70	129.21	-9.69	-23.12
Price / Book Value	45.07	45.07	10.05	4.02	2.28	2.94
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-9.88	-9.88	-5.97	86.01	-5.50	-15.36
Close Price ($)	8.01	8.01	11.65	10.55	5.48	8.53
High Price ($)	18.63	18.63	18.90	18.51	9.65	9.17
Low Price ($)	6.66	6.66	6.66	5.19	2.55	2.80
Market Cap ($ Cr)	558.89	558.89	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	7.73	7.73	0.84	0.00	0.00	0.00
Short term debt to equity ratio	--	--	0.01	0.00	0.00	0.00
Current Ratio	3.48	3.48	7.28	14.26	96.85	51.01
Quick Ratio	3.28	3.28	7.06	14.04	96.85	51.20
Interest Coverage	-27.66	-27.66	-64.94	--	--	-41.59

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	40.06	40.06	31.26	10.28	2,650.00	76.67
Asset Turnover	0.35	0.35	0.25	0.31	0.00	0.01
Receivable days	--	--	76.95	20.40	10,981.85	140.16
Inventory Days	--	--	121.44	46.30	-2,524.23	-83.10
Payable days	--	--	139.45	94.43	6,049.14	36.75
Cash Conversion Cycle	--	--	58.94	-27.73	2,408.48	20.31

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.